Feed/Companies/Syremis Therapeutics

Syremis Therapeutics

Every round on record, with the sources behind each and the investors on them.

Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health.

syremis.comLinkedInTel Aviv and Boston

LATEST ROUND

Series A

$165M · 2025-12-18

RAISED ON RECORD · USD

None

no verified round yet · plus 1 round still being checked

INVESTORS

2 leads

SOURCES

from 1 publisher

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series A

$165M · 2025-12-18

[ HISTORY ]

led by Dexcel Pharma, Third Rock Ventures

Round	Amount	Announced	Lead	Buzz
Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$165M	2025-12-18	Dexcel Pharma, Third Rock Ventures	No recent discussion
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source Amount added $165 million · businesswire.com

Syremis Therapeutics

Company

Rounds

Sources

Profile

Investors

Syremis Therapeutics

Rounds

Profile

Sources

Series A$165M2025-12-181 source

Investors

Series A$165M2025-12-186 investors